Pfizer/Pharmacia Flexes Market Strength: More Bulk For Medicaid/Medicare

Pfizer's $60 bil. stock acquisition of Pharmacia would create a combined company with over $23 bil. in annual U.S. drug sales with commensurate influence and bargaining power with large Rx drug purchasers